Mostrar el registro sencillo del ítem

Artículo

dc.creatorGómez-Regalado, María del Carmenes
dc.creatorMartín Bueno, Juliaes
dc.creatorHidalgo, Félixes
dc.creatorSantos Morcillo, Juan Luises
dc.creatorAparicio Gómez, Irenees
dc.creatorAlonso Álvarez, Estebanes
dc.creatorZafra-Gómez, Albertoes
dc.date.accessioned2024-04-30T09:25:23Z
dc.date.available2024-04-30T09:25:23Z
dc.date.issued2023-06
dc.identifier.issn1382-6689es
dc.identifier.issn1872-7077es
dc.identifier.urihttps://hdl.handle.net/11441/157319
dc.description.abstractThe present work assess the bioconcentration kinetics of atenolol (ATN) and carbamazepine (CBZ) in common marine organisms including Holothuria tubulosa, Anemonia sulcata and Actinia equina under controlled laboratory conditions. CBZ exhibited higher uptake and excretion rates resulting higher bioconcentration factor (BCF) (41–537 L/kg for CBZ vs 7–50 L/kg for ATN) although both are below the limits established by the European Union (EU). The measured BCF using kinetic data showed some differences with those predicted using the concentrations measured at the steady-state, probably explained because the steady state was not ready reached. The animal-specific BCF followed the order of Holothuria tubulosa > Actinia equina > Anemonia sulcata for ATN while was the opposite for CBZ. The study highlighted between-tissues differences in the digestive tract and the body wall of the Holothuria tubulosa. The work presented is the first to model bioconcentration of ATN and CBZ in holothurian and anemone animal models.es
dc.formatapplication/pdfes
dc.format.extent30 p.es
dc.language.isoenges
dc.publisherElsevieres
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectAtenololes
dc.subjectCarbamazepinees
dc.subjectUp-take/Depurationes
dc.subjectAnimal modeles
dc.subjectBenthic organismses
dc.titleBioconcentration of pharmaceuticals in benthic marine organisms (Holothuria tubulosa, Anemonia sulcata and Actinia equina) exposed to environmental contamination by atenolol and carbamazepinees
dc.typeinfo:eu-repo/semantics/articlees
dc.type.versioninfo:eu-repo/semantics/acceptedVersiones
dc.rights.accessRightsinfo:eu-repo/semantics/embargoedAccesses
dc.contributor.affiliationUniversidad de Sevilla. Departamento de Química Analíticaes
dc.relation.projectIDPID2020-117641RB-I00es
dc.relation.projectIDB.RNM.362. UGR20es
dc.relation.projectIDP20_00556es
dc.date.embargoEndDate2024-07-01
dc.relation.publisherversionhttps://www.sciencedirect.com/science/article/pii/S1382668923000893es
dc.identifier.doi10.1016/j.etap.2023.104147es
dc.contributor.groupUniversidad de Sevilla. FQM344: Análisis Químico Industrial y Medioambientales
dc.journaltitleEnvironmental Toxicology and Pharmacologyes
dc.publication.volumen100es
dc.publication.issue104147es
dc.contributor.funderMinisterio de Ciencia e Innovación (MICIN). Españaes
dc.contributor.funderJunta de Andalucíaes
dc.contributor.funderEuropean Commission (EC). Fondo Europeo de Desarrollo Regional (FEDER)es

FicherosTamañoFormatoVerDescripción
ETP_martin-bueno_2023_bioconce ...1.611MbIcon   [PDF] Ver/Abrir   Postprint. Accepted Version

Este registro aparece en las siguientes colecciones

Mostrar el registro sencillo del ítem

Attribution-NonCommercial-NoDerivatives 4.0 Internacional
Excepto si se señala otra cosa, la licencia del ítem se describe como: Attribution-NonCommercial-NoDerivatives 4.0 Internacional